Justin Bekelman

Justin Bekelman is the co-founder and CEO of Daymark Health, a Philadelphia-based value-based oncology company building a tech-enabled medical group that wraps clinical, mental health, and social support around people facing cancer. A radiation oncologist with roughly 200 published research articles, he spent two decades at the University of Pennsylvania, where he founded the Penn Center for Cancer Care Innovation at the Abramson Cancer Center before leaving to build a company that contracts directly with health plans to take on total cost of care. Daymark launched publicly in 2025 with $11.5M in seed funding and closed a $20M Series A in September 2025.